Sponsored by Everlytic Everlytic recently opened submissions to the first-ever You Mailed It Email Awards – an opportunity for South African marketers to showcase…
Egyptian on-demand medicine delivery platform Chefaa has raised a pre-Series A investment round from US venture capital fund and accelerator 500 Startups, Saudi Arabian fund Vision Ventures, Womena and a number of other investors.
The startup was founded 2017 by Dr Rasha Rady and Doaa Aref (pictured above, left to right). The platform allows patients to order prescriptions and other products from pharmacies.
The deal was announced by tech publication Menabytes in an article yesterday. The startup did not disclose the exact size of the investment, other than to say that it was a seven-figure dollar investment.
On-demand medicine delivery platformChefaa was founded in 2017 by Dr Rasha Rady and Doaa Aref
Chefaa has previously raised a previous investment from a number of investors in August last year, including 500 Startups and Flat6Labs.
While the amount was not disclosed, data from Crunchbase reveals the startup has previously raised $304 000 across two previous rounds.
In a tweet yesterday Vision Ventures said the investment will help the startup to expand its services to ensure basic medicines and personal care products are easily available to everyone in the region.
Menabytes reported that the startup had recently launched a white-label product as well and now plans to use the investment to grow its operations team and launch a B2B service to serve SMEs.
Featured image (left to right): Chefaa founders Dr Rasha Rady and Doaa Aref (Facebook)